GSK2485852
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK2485852, covering 2017-07-07 to 2017-07-07. Get the full timeline:
Most recent: Clinical Trial Update: A First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2485852 in Chronically Infected Hepatitis C Subjects [Phase 1]